Home NDC 0093-5214 Moexipril Hydrochloride and Hydrochlorothiazide
Product NDC 0093-5214
11-digit product format 000935214
Labeler code 0093
Product ID 0093-5214_cfc0697a-f5a7-4f1a-a107-9fd1eb2bf479
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Moexipril Hydrochloride and Hydrochlorothiazide
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA076980
Marketing category ANDA
Marketing start 2007-03-07
Marketing end 2019-11-30
Substance MOEXIPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Active strength 15 mg/1; mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0093-5214-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0093-5214-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0093-5214-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0093-5214-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0093-5214-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0093-5214-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0093-5214-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0093-5214-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0093-5214-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0093-5214-01 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0093-5214-01 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0093-5214-01 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE 12.5MG;7.5MG TABLET / ORAL 2007-03-07 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE 25MG;15MG TABLET / ORAL RS 2007-03-07 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE 12.5MG;15MG TABLET / ORAL 2007-03-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL 2007-03-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL RS 2007-03-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL 2007-03-07 c2088c7a36db…2026-09-14 22:38:34 2026-08 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL 2007-03-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL RS 2007-03-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL 2007-03-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL 2007-03-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL RS 2007-03-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL 2007-03-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL 2007-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL RS 2007-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL 2007-03-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL 2007-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL RS 2007-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL 2007-03-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076980-002 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 25MG;15MG TABLET / ORAL AB RS 2007-03-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076980-003 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;15MG TABLET / ORAL AB 2007-03-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076980-001 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE 12.5MG;7.5MG TABLET / ORAL AB 2007-03-07 79d66fd596c7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 114 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT 0J48LPH2TH MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 MOEXIPRIL HYDROCHLORIDE ACTIVE INGREDIENT Q1UMG3UH45 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 HYDROCHLOROTHIAZIDE ACTIVE MOIETY 0J48LPH2TH MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 MOEXIPRILAT ACTIVE MOIETY H3753190JS MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 FD&C YELLOW NO. 5 INACTIVE INGREDIENT I753WB2F1M MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 POLYVINYL ALCOHOL INACTIVE INGREDIENT 532B59J990 MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 POVIDONE K29/32 INACTIVE INGREDIENT 390RMW2PEQ MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 SODIUM BICARBONATE INACTIVE INGREDIENT 8MDF5V39QO MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 TALC INACTIVE INGREDIENT 7SEV7J4R1U MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 8